You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ACP-196

Showing 26 - 50 of 300
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib,

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Acalabrutinib
  • CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 16, 2022

Hepatic Insufficiency Trial in Miami, Orlando, Knoxville (ACP-196)

Completed
  • Hepatic Insufficiency
  • ACP-196
  • Miami, Florida
  • +2 more
Apr 28, 2021

Healthy Volunteers Trial in Tempe (ACP-196, Moxifloxacin 400 mg, Placebo)

Completed
  • Healthy Volunteers
  • ACP-196
  • +2 more
  • Tempe, Arizona
    Celerion
Apr 28, 2021

Waldenström Macroglobulinemia (WM) Trial in Worldwide (Acalabrutinib (ACP-196))

Active, not recruiting
Has Results
  • Waldenström Macroglobulinemia (WM)
  • Acalabrutinib (ACP-196)
  • Santa Barbara, California
  • +37 more
Mar 17, 2022

Chronic Lymphocytic Leukemia, CLL/SLL Trial in New York (Acalabrutinib)

Withdrawn
  • Chronic Lymphocytic Leukemia
  • CLL/SLL
  • New York, New York
    Weill Cornell Medicine
Mar 25, 2022

CNS Lymphoma Trial in Chapel Hill, Winston-Salem (Acalabrutinib, Isavuconazole)

Recruiting
  • Central Nervous System Lymphoma
  • Chapel Hill, North Carolina
  • +1 more
Mar 24, 2022

Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Atlanta (drug, biological,

Recruiting
  • Grade 1 Follicular Lymphoma
  • +7 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Dec 7, 2021

Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Miami (Acalabrutinib,

Terminated
Has Results
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • Miami, Florida
    University of Miami
Aug 23, 2022

Mantle Cell Lymphoma Trial in New York (Acalabrutinib, Lenalidomide, Rituximab)

Recruiting
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medicine
Oct 29, 2021

Chronic Lymphocytic Leukemia Trial in Poland, United Kingdom (Ceralasertib, Acalabrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Kraków, Poland
  • +10 more
Dec 2, 2022

Healthy Volunteers Trial in Tempe (Acalabrutinib, SmartPill®)

Completed
  • Healthy Volunteers
  • Tempe, Arizona
    Celerion
Jun 2, 2021

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

DLBCL Trial in Houston (Acalabrutinib, Cyclophosphamide, Doxorubicin Hydrochloride)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Chronic Lymphoid Leukemia Trial in Austria, Germany (Acalabrutinib)

Recruiting
  • Chronic Lymphoid Leukemia
  • Acalabrutinib
  • Innsbruck, Austria
  • +19 more
Mar 21, 2022

Mantle Cell Lymphoma Trial in Houston (Acalabrutinib, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Feb 24, 2021

Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

Recruiting
  • Mantle Cell Lymphoma
  • New Orleans, Louisiana
  • +5 more
Dec 13, 2022

Multiple Myeloma (MM) Trial in Baltimore, Leicester, London (acalabrutinib)

Completed
Has Results
  • Multiple Myeloma (MM)
  • Baltimore, Maryland
  • +2 more
Jul 15, 2020

Advanced Haematological Malignancies Trial in Worldwide (AZD4573, Acalabrutinib)

Recruiting
  • Advanced Haematological Malignancies
  • Duarte, California
  • +38 more
Jul 22, 2022

DLBCL, Richter Syndrome Trial in United Kingdom, United States (acalabrutinib, vistusertib)

Terminated
Has Results
  • DLBCL
  • Richter Syndrome
  • Fairway, Kansas
  • +10 more
Jan 4, 2021

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Venetoclax, Chemoimmunotherapy)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Fountain Valley, California
  • +201 more
Jan 16, 2023

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Chandler, Arizona
  • +107 more
Mar 8, 2022

Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (KRT-232, acalabrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Goshen, Indiana
  • +44 more
Aug 3, 2022

NSCLC Trial in Goodyear (Pembrolizumab, Acalabrutinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Goodyear, Arizona
    Western Regional Medical Center/Cancer Treatment Center of Ameri
Aug 22, 2019

Metastatic Pancreatic Cancer Trial in United States (ACP-196, Nab-paclitaxel, Gemcitabine)

Terminated
Has Results
  • Metastatic Pancreatic Cancer
  • ACP-196
  • +2 more
  • Ventura, California
  • +9 more
Aug 23, 2019

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib (ACP-196), Rituximab, Idelalisib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Acalabrutinib (ACP-196)
  • +3 more
  • Chandler, Arizona
  • +156 more
Jun 2, 2022